(1)
Reich, K.; Goodfield, M.; Green, L.; Nograles, K.; Levi, E.; Langley, R. G. Safety and Efficacy of Apremilast Through 104 Weeks in Patients Swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. J of Skin 2017, 1, s32.